Antitumor Activity of Ficlatuzumab in Combination with Tivozanib On Primary Human Renal Cell Carcinoma Xenografts

被引：0
|
作者：
Meetze, K. [1 ]
Connolly, K. [1 ]
Feng, B. [1 ]
Rideout, W. [1 ]
Gyuris, J. [1 ]
Han, M. [1 ]
机构：
[1] AVEO Pharmaceut Inc, Drug Discovery, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
301
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [31] Tivozanib in renal cell carcinoma: a new approach to previously treated disease
    Salgia, Nicholas J.
    Zengin, Zeynep B.
    Pal, Sumanta K.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [32] Significant antitumor activity of cationic multilamellar liposomes containing human interferon-β gene in combination with 5-fluorouracil against human renal cell carcinoma
    Yamamoto, Kosuke
    Mizutani, Yoichi
    Nakanishi, Hiroyuki
    Fujiwara, Jun
    Ishida, Hirokazu
    Toiyama, Daisuke
    Abe, Koichi
    Hayashi, Issei
    Okada, Koichi
    Kawauchi, Akihiro
    Mizuno, Masaaki
    Yoshida, Jun
    Miki, Tsuneharu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (03) : 565 - 571
  • [33] Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
    Staffhorst, Rutger W. H. M.
    van der Born, Kasper
    Erkelens, Caroline A. M.
    Hamelers, Irene H. L.
    Peters, Godefridus J.
    Boven, Epie
    de Kroon, Anton I. P. M.
    ANTI-CANCER DRUGS, 2008, 19 (07) : 721 - 727
  • [34] FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma
    Chang, Elaine
    Weinstock, Chana
    Zhang, Lijun
    Fiero, Mallorie H.
    Zhao, Miao
    Zahalka, Eias
    Ricks, Tiffany K.
    Zirkelbach, Jeanne Fourie
    Qiu, Junshan
    Yu, Jingyu
    Chen, Xiao Hong
    Bhatnagar, Vishal
    Goldberg, Kirsten B.
    Tang, Shenghui
    Kluetz, Paul G.
    Pazdur, Richard
    Ibrahim, Amna
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    CLINICAL CANCER RESEARCH, 2022, 28 (03) : 441 - 445
  • [35] Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice
    Kubota, T
    Matsuzaki, SW
    Hoshiya, Y
    Watanabe, M
    Kitajima, M
    Asanuma, F
    Yamada, Y
    Koh, JI
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 64 (02) : 115 - 121
  • [36] Antiangiogenic and antitumor effects of a protein kinase Cβ inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts
    Teicher, BA
    Menon, K
    Alvarez, E
    Galbreath, E
    Shih, C
    Faul, MM
    ANTICANCER RESEARCH, 2001, 21 (05) : 3175 - 3184
  • [37] Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma
    Sakellakis, Minas
    Zakopoulou, Roubini
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [38] Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma
    Cowey, C. Lance
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 519 - 527
  • [39] Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
    Yalcin, Suayib
    Lacin, Sahin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7779 - 7785
  • [40] COST-EFFECTIVENESS OF TIVOZANIB IN ADVANCED RENAL CELL CARCINOMA IN THE US
    Ta, R.
    VALUE IN HEALTH, 2024, 27 (06) : S73 - S73
12345